Stock listing
OTC:BITRF Biotron Limited Stock
US listing (OTC) of Biotron Limited · home listing ASX:BIT
Follow Biotron Limited into a list and get an email when it puts out news.
Share price · OTC:BITRF
$0.0028 USD 0.0000 (0.0%)
Close on Nov 12, 2026
- Day range
- $0.0028 – $0.0028 USDNov 12, 2026
- 52-week range
- $0.0011 – $0.1014 USDLowest and highest trades, Nov 14, 2025 – Nov 12, 2026
- Traded on an average day
- $18 USDMedian day 0 shares · 50 days with no trades · last 3 months, Aug 19, 2026 – Nov 12, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:BIT · Home | $0.0020 AUD | 0.0000 (0.0%) | 1,019,027 | $0.0020 | $0.0020 | $0.0020 | $0.0020 | Close on Nov 20, 2026 |
| OTC:BITRF | $0.0028 USD | 0.0000 (0.0%) | — | $0.0028 | $0.0028 | $0.0028 | $0.0028 | Close on Nov 12, 2026 |
Daily closes
Last 3 months, Aug 19, 2026 – Nov 12, 2026 · OTC:BITRF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0028 | 0.0000 | 0.0% | $0.0028 | $0.0028 | $0.0028 | 0 | |
| $0.0028 | +0.0013 | +86.7% | $0.0028 | $0.0028 | $0.0028 | 20,000 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | +0.0002 | +15.4% | $0.0015 | $0.0015 | $0.0015 | 400,000 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | -0.0002 | -13.3% | $0.0013 | $0.0013 | $0.0013 | 110,000 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | 0.0000 | 0.0% | $0.0015 | $0.0015 | $0.0015 | 0 | |
| $0.0015 | +0.0002 | +15.4% | $0.0015 | $0.0015 | $0.0015 | 100,000 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 20,000 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | 0.0000 | 0.0% | $0.0013 | $0.0013 | $0.0013 | 0 | |
| $0.0013 | -0.0007 | -35.0% | $0.0400 | $0.0400 | $0.0013 | 40,000 |
Splits
2 splits since 2014 · OTC:BITRF · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 54-for-49 | Split | |
| 33-for-31 | Split |
- Ticker
- OTC:BITRF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 8, 2026
Executive Director CEO Commences - Appendix 3X
Latest deck · Sep 3, 2026
Biotech Showcase, Melbourne (September 2026)
Conference · 12 slides
Latest news
Executive Director CEO Commences - Appendix 3X
Nov 8, 2026
Closed $0.0015 (0.0%) on Nov 9, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Oct 27, 2026
Closed $0.0015 (0.0%) on Oct 28, 2026
Biotron Receives Additional $208,463 Tax Refund
Oct 22, 2026
Closed $0.0015 (0.0%) on Oct 23, 2026
Annual Report/Notice of AGM/Proxy Form
Oct 22, 2026
Closed $0.0015 (0.0%) on Oct 23, 2026
Director Appointment Michael Thurn & Appendix 3X
Oct 18, 2026
Closed $0.0015 (0.0%) on Oct 19, 2026
Appointment of CEO and Executive Director
Oct 13, 2026
Closed $0.0015 (0.0%) on Oct 14, 2026
Resignation of Managing Director and Appendix 3Z
Sep 13, 2026
Closed $0.0013 (0.0%) on Sep 14, 2026
Change of Share Registry
Sep 3, 2026
Closed $0.0013 (0.0%) on Sep 4, 2026
Investor Presentation
Sep 2, 2026
Closed $0.0013 (0.0%) on Sep 3, 2026
Appendix 4G
Aug 26, 2026
Closed $0.0013 (0.0%) on Aug 27, 2026
Biotron Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 98 in all · newest Nov 8, 2026 · oldest 2016
- Decks
- 101 decks · latest Sep 3, 2026
Where Biotron Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:BIT · Home listing | ASX | Australia | AUD |
| OTC:BITRF · This page | OTC | United States | USD |
Cash and shares
Sep 2026 deck · Biotron — Biotech Showcase, Melbourne (September 2026)
- Shares outstanding
- 228 million
Valuation
Price/book 1.9× against a median of 0.8×: 8th lowest of 11 Biotechnology companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $4.02M AUD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.9×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Biotron Limited · ASX:BIT | US$3.69M | US$2.66M | n/a | n/a | n/a | 1.9× | n/a | 0.0× | n/a |
| AdAlta Ltd. · ASX:1AD | US$4.25M | US$3.40M | n/a | n/a | n/a | 17.4× | n/a | 0.0× | n/a |
| Percheron Therapeutics Limited · ASX:PER | US$3.94M | US$1.27M | n/a | n/a | n/a | 0.8× | n/a | 0.0× | n/a |
| Lantern Pharma Inc. · NASDAQ:LTRN | US$3.89M | −US$3.69M | n/a | n/a | n/a | 2.8× | n/a | 0.0× | 2.80 |
| Silo Pharma, Inc. · NASDAQ:SILO | US$3.77M | −US$4.28M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | 1.23 |
| Alzamend Neuro, Inc. · NASDAQ:ALZN | US$3.74M | −US$3.85M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 2.00 |
| Reviva Pharmaceuticals Holdings, Inc. · NASDAQ:RVPH | US$3.68M | −US$13.77M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 1.57 |
| Liminatus Pharma, Inc. · NASDAQ:LIMN | US$3.37M | US$1.80M | n/a | n/a | n/a | 11.2× | n/a | 4.8× | 0.94 |
| Xenetic Biosciences, Inc. · NASDAQ:XBIO | US$3.28M | −US$2.53M | n/a | −0.8× | n/a | 0.7× | −123.7% | 0.0× | 1.46 |
| Aprea Therapeutics, Inc. · NASDAQ:APRE | US$3.25M | −US$34.60M | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 0.73 |
| Spago Nanomedical AB · OMXSTO:SPAGO | US$3.20M | US$22,063 | n/a | 5.6× | n/a | 1.0× | n/a | 0.0× | n/a |
| Median of the others | US$3.71M | −US$3.11M | 2.4× | 0.8× | −123.7% | 0.0× | 1.46 |
Team and board
Officers
| Officer | Role |
|---|---|
| Marcelo Mora | Company Secretary |
Board
| Director | Role |
|---|---|
| Paul Kasian | Independent and Non-Executive Chairman |
| Graeme Wald | Independent and Non-Executive Director |
| Michael J. Thurn | Independent and Non-Executive Director |
| Michael Medway | Independent and Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Aug 27, 2025 | +33.3% |
| Q2 2025 | Feb 28, 2025 | −55.6% |
| Q2 2023 | Feb 17, 2023 · After close | 0.0% |
| Q4 2022 | Aug 19, 2022 · After close | −1.6% |
| Q2 2022 | Feb 23, 2022 | −3.2% |
| Q4 2021 | Aug 27, 2021 | 0.0% |
| Q2 2021 | Feb 23, 2021 | −6.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Biotech Showcase, Melbourne (September 2026) | Conference | 12 slides | Sep 3, 2026 |
| Investor Presentation (November 2025) | Investor deck | 32 slides | Nov 11, 2025 |
| Investor Presentation (October 2025) | Investor deck | 15 slides | Oct 15, 2025 |
| Shareholder Meeting (November 2024) | Shareholder meeting | 20 slides | Nov 28, 2024 |
| Shareholder Meeting (November 2024) | Shareholder meeting | 17 slides | Nov 28, 2024 |
| Investor Presentation (June 2024) | Investor deck | 12 slides | Jun 26, 2024 |
| Shareholder Meeting (November 2023) | Shareholder meeting | 14 slides | Nov 22, 2023 |
| Shareholder Meeting (November 2023) | Shareholder meeting | 12 slides | Nov 22, 2023 |
| Investor Presentation (October 2023) | Investor deck | 14 slides | Oct 24, 2023 |
| Investor Presentation (October 2023) | Investor deck | 13 slides | October 2023 |
Show 50 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (November 2022) | Shareholder meeting | 13 slides | Nov 16, 2022 |
| Investor Presentation (November 2022) | Investor deck | 13 slides | Nov 11, 2022 |
| Investor Presentation (November 2022) | Investor deck | 12 slides | November 2022 |
| Investor Presentation (November 2021) | Investor deck | 17 slides | Nov 25, 2021 |
| Shareholder Meeting (November 2021) | Shareholder meeting | 16 slides | Nov 23, 2021 |
| Shareholder Meeting (November 2021) | Shareholder meeting | 13 slides | Nov 23, 2021 |
| Investor Presentation (October 2021) | Investor deck | 13 slides | October 2021 |
| Shareholder Meeting (November 2020) | Shareholder meeting | 15 slides | Nov 19, 2020 |
| Shareholder Meeting (November 2020) | Shareholder meeting | 14 slides | Nov 19, 2020 |
| Investor Presentation (October 2020) | Investor deck | 11 slides | Oct 14, 2020 |
| Investor Presentation (October 2020) | Investor deck | 10 slides | October 2020 |
| Shareholder Meeting (November 2019) | Shareholder meeting | 22 slides | Nov 26, 2019 |
| Shareholder Meeting (November 2019) | Shareholder meeting | 19 slides | Nov 26, 2019 |
| Australia Biotech Invest and Partnering 2019 | Conference | 13 slides | Oct 31, 2019 |
| 2019 BIO International Convention | Conference | 15 slides | Jun 7, 2019 |
| BIO 2019 | Conference | 13 slides | June 2019 |
| Shareholder Meeting (November 2018) | Shareholder meeting | 22 slides | Nov 20, 2018 |
| Shareholder Meeting (November 2018) | Shareholder meeting | 19 slides | November 2018 |
| Investor Presentation (October 2018) | Investor deck | 17 slides | Oct 25, 2018 |
| Biotech Showcase 2018 | Conference | 22 slides | January 2018 |
| Shareholder Meeting (November 2017) | Shareholder meeting | 19 slides | Nov 20, 2017 |
| Shareholder Meeting (November 2017) | Shareholder meeting | 16 slides | Nov 20, 2017 |
| Investor Presentation (October 2017) | Investor deck | 15 slides | Oct 6, 2017 |
| Biotech Showcase 2017 | Conference | 26 slides | Jan 13, 2017 |
| Biotech Showcase 2017 | Conference | 21 slides | January 2017 |
| Biotech Showcase 2017 | Conference | 25 slides | January 2017 |
| Shareholder Meeting (November 2016) | Shareholder meeting | 22 slides | Nov 22, 2016 |
| Shareholder Meeting (November 2016) | Shareholder meeting | 19 slides | Nov 22, 2016 |
| Biotech Invest 2016 | Conference | 12 slides | May 4, 2016 |
| Singapore Biotech Invest 2016 / Asia Biotech Invest 2016 | Conference | 11 slides | May 2016 |
| Biotech Showcase 2016 | Conference | 21 slides | January 2016 |
| Shareholder Meeting (November 2015) | Shareholder meeting | 16 slides | Nov 24, 2015 |
| Shareholder Meeting (November 2015) | Shareholder meeting | 13 slides | Nov 24, 2015 |
| Investor Presentation (October 2015) | Investor deck | 10 slides | Oct 6, 2015 |
| Australia Biotech Invest 2015 | Conference | 9 slides | October 2015 |
| Investor Presentation (August 2015) | Investor deck | 14 slides | Aug 20, 2015 |
| Investor Presentation (May 2015) | Investor deck | 11 slides | May 28, 2015 |
| Broker Meets Biotech 2015 | Conference | 10 slides | May 2015 |
| Biotech Showcase 2015 | Conference | 21 slides | January 2015 |
| Investor Presentation (December 2014) | Investor deck | 17 slides | Dec 4, 2014 |
This page holds 50 of 101 decks. Open Decks
Financials
Annual, in AUD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.81M | 1.65M | 1.43M | 1.56M | 1.46M | 803.0K | 1.07M | 1.62M | 1.66M | |
| Cost of revenue | 1.91K | 11.1K | 40.5K | 43.3K | 45.3K | 47.3K | 50.1K | 12.5K | 11.6K | 13.1K |
| Gross profit | -1.91K | 1.81M | 1.65M | 1.39M | 1.51M | 1.41M | 752.9K | 1.06M | 1.61M | 1.65M |
| Research and development | 683.3K | 535.4K | 3.62M | 3.23M | 2.82M | 3.14M | 2.86M | 1.12M | 1.69M | 3.16M |
| Selling, general and administrative | 1.24M | 769.3K | 528.5K | 696.7K | 228.0K | 228.0K | 237.2K | 299.6K | 275.7K | 242.0K |
| Operating income | -1.93M | -338.8K | -5.15M | -5.04M | -2.78M | -4.32M | -4.05M | -2.77M | -1.61M | -4.40M |
| Depreciation and amortization | 1.91K | 11.1K | 40.5K | 43.3K | 45.3K | 47.3K | 50.1K | 12.5K | 11.6K | 13.1K |
| EBITDA | -1.93M | -327.6K | -5.11M | -5.00M | -2.73M | -4.27M | -4.00M | -2.76M | -1.60M | -4.38M |
| Interest expense | 14.6K | 1.09K | 4.39K | 5.05K | 1.26K | 5.12K | 5.12K | 0 | 0 | |
| Income before tax | -2.04M | -318.6K | -3.44M | -4.92M | -2.78M | -4.61M | -4.33M | -2.68M | -1.59M | -4.71M |
| Income tax | -525.9K | -1.81M | -1.65M | -1.43M | 5 | -1.41M | -753.0K | -1.07M | -1.62M | -1.61M |
| Net income | -1.52M | -318.6K | -3.44M | -3.49M | -2.78M | -3.19M | -3.58M | -1.61M | -1.59M | -3.09M |
| Earnings per share, basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -0.01 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.55M | 931.7K | 393.2K | 3.98M | 1.74M | 4.21M | 7.66M | 5.74M | 1.54M | 1.99M |
| Short-term investments | 0 | 0 | ||||||||
| Receivables | 18.0K | 7.08K | 18.2K | 23.1K | ||||||
| Inventory | 811 | |||||||||
| Current assets | 1.59M | 955.4K | 426.8K | 4.03M | 1.76M | 4.26M | 7.72M | 5.78M | 1.60M | 2.03M |
| Property, plant and equipment | 4.59K | 12.6K | 49.9K | 89.7K | 30.9K | 73.2K | 46.3K | 17.9K | 29.5K | |
| Total assets | 3.74M | 980.4K | 493.5K | 4.14M | 1.91M | 4.33M | 7.83M | 5.86M | 1.62M | 2.06M |
| Accounts payable | 50.6K | 89.9K | 285.5K | 285.2K | 310.9K | 138.2K | 310.0K | 158.3K | 135.8K | 344.2K |
| Current liabilities | 817.9K | 428.5K | 737.5K | 955.8K | 750.6K | 451.2K | 840.8K | 412.1K | 337.7K | 619.5K |
| Total debt | 7.13K | 45.3K | 77.2K | 6.35K | 44.0K | 44.0K | ||||
| Total liabilities | 817.9K | 428.5K | 737.5K | 962.5K | 813.6K | 463.5K | 853.2K | 418.0K | 337.7K | 619.5K |
| Shareholders' equity | 2.92M | 551.9K | -244.0K | 3.17M | 1.09M | 3.86M | 6.97M | 5.44M | 1.28M | 1.44M |
| Shares outstanding | 2.07B | 999.2M | 902.2M | 820.8M | 724.8M | 724.8M | 675.5M | 577.5M | 397.2M | 377.6M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.78M | -565.8K | -3.57M | -3.29M | -2.44M | -3.41M | -3.08M | -1.50M | -1.84M | -2.83M |
| Capital spending | -4 | -3.07K | -4 | -5 | 0 | -5.72K | -5.72K | -40.9K | -40.9K | -5.50K |
| Free cash flow | -1.78M | -568.9K | -3.57M | -3.29M | -2.44M | -3.41M | -3.08M | -1.54M | -1.84M | -2.84M |
| Cash from investing | 111.5K | -3.07K | 0 | 0 | 0 | -5.72K | -5.72K | -52.9K | -52.9K | -11.9K |
| Cash from financing | 2.29M | 1.11M | -22.6K | 5.53M | -33.2K | -37.0K | 5.00M | 5.75M | 1.40M | 1.41M |
| Dividends paid | -5.11M | -4.73M | 0 | |||||||
| Share buybacks | -236.6K | 1.28M | 19.8K | -427.8K | -427.8K | 0 | -275.4K | -291.7K | -255.5K | -163.6K |
| Change in cash | 622.2K | 538.5K | -3.59M | 2.24M | -2.47M | -3.45M | 1.92M | 4.20M | -444.4K | -1.43M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Executive Director CEO Commences - Appendix 3X | Nov 8, 2026 | Management or board change | ASX |
| Quarterly Activities/Appendix 4C Cash Flow Report | Oct 27, 2026 | Quarterly report | ASX |
| Biotron Receives Additional $208,463 Tax Refund | Oct 22, 2026 | Results | ASX |
| Annual Report/Notice of AGM/Proxy Form | Oct 22, 2026 | Meeting notice | ASX |
| Director Appointment Michael Thurn & Appendix 3X | Oct 18, 2026 | Management or board change | ASX |
| Appointment of CEO and Executive Director | Oct 13, 2026 | Management or board change | ASX |
| Resignation of Managing Director and Appendix 3Z | Sep 13, 2026 | Management or board change | ASX |
| Change of Share Registry | Sep 3, 2026 | Other filings | ASX |
| Investor Presentation | Sep 2, 2026 | Other filings | ASX |
| Appendix 4G | Aug 26, 2026 | Other filings | ASX |
All 98 filings
Cap table
Built by 6ix from Biotron Limited’s releases
- Common shares
- 2,785,204,977
- Fully diluted
- 2,785,204,977
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 2,785,204,977 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 2,785,204,977 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Graeme Wald | Independent and Non-Executive Director · Since at least Nov 5, 2026 |
| Marcelo Mora | Company Secretary · Since at least Nov 5, 2026 |
| Michael J. Thurn | Independent and Non-Executive Director · Since at least Nov 5, 2026 |
| Michael Medway | Independent and Non-Executive Director · Since at least Nov 5, 2026 |
| Paul Kasian | Independent and Non-Executive Chairman · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Biotron Limited.